期刊論文| 1. | (1998)。United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy。Ann Intern Med，128，165-175。   |
| 2. | Holman, R. R.(1998)。Assessing the potential for a-glucosidase inhibitors in prediabetic states。Diabets Res Clin Pract，40，21-25。 |
| 3. | (1998)。Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes。Lancet，352，854-865。 |
| 4. | Quinn, L.(2001)。Pharmacologic management of the patient with type 2 diabetes。Nurs Clin North Am，36，217-242。 |
| 5. | Turner, R. C.、Cull, C. A.、Frighi, V,、Holman, R. R.(1999)。Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies。JAMA，281，2005-2012。 |
| 6. | Krentz, A. J.、Bailey C. J.(2005)。Oral antidiabetic agents: current role in type 2 diabetes mellitus。Drugs，65，385-411。 |
| 7. | Wright, A.、Burden, A. C.、Paisey, R. B.、Cull, C. A.、Holman, R. R.(2002)。Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U,K,Prospective Diabetes Study。Diabetes Study，25，330-336。 |
| 8. | Chipkin, S. R.(2005)。How to select and combine oral agents for patients with type 2 diabetes mellitus。Am J Med，118，4-13。 |
| 9. | DeFronzo, R. A.(1999)。Pharmacologic therapy for type 2 diabetes mellitus。Ann Intern Med，131，281-303。 |
| 10. | Riddle, M.(2000)。Combining sulfonylureas and other oral agents。Am J Med，108，15-22。 |
| 11. | Inzucchi, S. E.(2002)。Oral antihyperglycemic therapy for type 2 diabetes: scientific review。JAMA，287，360-372。 |
| 12. | BHW, R. L.(1999)。A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes。Diabetes Care，22，463-467。 |
| 13. | Harris, S. B.、Lank, C. N.(2004)。Recommendations from the Canadian Diabetes Association. 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors。Can Fam Physician，50，425-433。 |
| 14. | UK Prospective Diabetes Study Group(1998)。Intensive Blood Glucose Control With Sulphonylureas or Insulin Compared With Conventional Treatment and Risk of Complications in Patients With Type 2 Diabetes (UKPDS 33)。The Lancet，352(9131)，837-853。 |